Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ALMR stock hub

Alamar Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALMRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALMR

In the news

Latest news · ALMR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-33.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-15.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALMR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002104204
Company name	Alamar Biosciences, Inc.
Country	United States
Country code	US
Cusip	010911105
Employees	222
Employees Change	86%
Employees Change Percent	63.24
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2026-04-17
Isin	US0109111056
Last refreshed	2026-05-10
Market cap	$1.6B
Market cap category	Small-Cap
Price	$23.96
Rev Per Employee	334,283.78x
Sector	Healthcare
Sic	3826
Symbol	ALMR
Tags	pharmaceuticals
Website	https://alamarbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.82%
EV/Sales	22.18x
FCF yield	-3.61%
P/B ratio	21.49x
P/S ratio	22.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-42.22%
EBITDA Margin	-38.5%
Gross margin	56.2%
Gross Profit	$41.7M
Net Income	$-29.8M
Net Income Growth Years	1%
Pretax Margin	-39.29%
Profit Margin	-40.18%
Profit Per Employee	$-134,320
ROA	-13.53
ROCE	-26.95
ROE	-33.57
ROIC	-15.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth	195.17x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.51
Assets	$140M
Cash	$30M
Current Assets	$94.7M
Current Liabilities	$23.7M
Debt	$41.5M
Debt Equity	$0.55
Equity	$76M
Interest Coverage	-78.14
Liabilities	$64M
Long Term Assets	$45.3M
Long Term Liabilities	$40.2M
Net Cash	$-11.5M
Net Cash By Market Cap	$-0.7
Net Debt Equity	$0.15
Tangible Book Value	$-160.9M
Tangible Book Value Per Share	$-5.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.99
Inventory Turnover	1.23
Net Working Capital	$43.1M
Quick ratio	1.8
Working Capital	$71M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	27.2
All Time High Change	-11.91%
All Time High Date	2026-04-28
All Time Low	21.5
All Time Low Change	11.44%
All Time Low Date	2026-04-17
ATR	1.96
Beta1y	-22.66
High	25.21
High52	27.2
High52 Date	2026-04-28
High52ch	-11.91%
Low	23.12
Low52	21.5
Low52 Date	2026-04-17
Low52ch	11.44%
Premarket Change Percent	-2.79
Premarket Price	$23
Premarket Volume	3,147
RSI	58.1
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	2.56x
Sortino ratio	3.84
Tr1w	-7.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-31.3M
Operating margin	-42.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,114,150%
Float Percent	48.55%
Net Borrowing	10,000,000
Shares Insiders	13.8%
Shares Institutions	0.87%
Shares Out	68,208,925

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.9M
Average Volume	642,092.44x
Bv Per Share	-5.46
CAPEX	$-5.4M
Ch1w	-7.17
Change	1.27%
Change From Open	3.63
Close	23.66
Days Gap	-2.28
Depreciation Amortization	2,764,000
Dollar Volume	7,297,617
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-31.3M
EBITDA	$-28.6M
EPS	$-1.07
F Score	0
FCF	$-59M
FCF EV Yield	-3.58x
FCF Per Share	$-0.86
Financing CF	10,836,000
Fiscal Year End	December
Founded	2,018
Income Tax	$665,000
Investing CF	46,176,000
Ipr	40.94
Iprfo	6.02
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Split Type	Never
Net CF	3,232,000
Next Earnings Date	2026-08-23
Open	23.12
Optionable	No
Position In Range	40.19
Post Close	23.96
Postmarket Change Percent	1.96
Postmarket Price	$24.43
Ppne	36,628,000
Pre Close	23.66
Price Date	2026-05-08
Relative Volume	0.47x
Revenue	74,211,000x
SBC By Revenue	3.87x
Share Based Comp	2,870,000
Tax By Revenue	0.9x
Us State	California
Volume	304,575
Z Score	-1.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALMR pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ALMR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Float: +48.5% of shares outstanding

Insider ownership

+13.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ALMR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALMR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALMR stock rating?

Alamar Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALMR analysis?

The full report lives at /stocks/ALMR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALMR?

The latest report frames ALMR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALMR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.